Dongcheng Biochemicals USA

Dongcheng Biochemicals USA is the North American subsidiary of Yantai Dongcheng Pharmaceutical Group, a leading global manufacturer of biochemical active pharmaceutical ingredients (APIs). The company is recognized as one of the world's largest producers of heparin sodium and chondroitin sulfate, providing essential raw materials for the treatment of cardiovascular diseases and joint health. In addition to its API portfolio, the parent company has established a significant presence in the radiopharmaceutical industry through strategic acquisitions and internal development. The US office serves as a critical link for business development, regulatory affairs, and supply chain management for the American market. Dongcheng continues to expand its footprint in nuclear medicine, focusing on both diagnostic and therapeutic radiopharmaceuticals.